Skip to content
luis_lopez_fernandez_w4_copy

Affiliation

Hospital General Universitario Gregorio Marañón

Country

Spain

1. Current Status, Position

Dr. Luis Andrés López Fernández is currently a researcher at Gregorio Marañón Hospital. He is responsible of the Laboratory of Pharmacogenetics included in the Pharmacy Department.

2. Education

He studied Biology at Alcala University and became licensed biologist in 1990. In 1994 he obtained a PhD in Genetics at Alcala University for his work on molecular biology of gametogenesis in Centro de Investigaciones Biológicas (Madrid, Spain). Then, he moved to the Institut National de la Santé et de la Researche Médicale (1996 – 1998, Unité 470, Nice, France); Centro de Investigaciones Biológicas (1998-2000, Madrid, Spain), Centro Nacional de Biotecnología (2000-2006) and finally Hospital General Univesrsitario Gregorio Marañón (2006- present). 

3. Research Area

His research focuses on pharmacogenetics biomarkers discovery and clinical implementation. He leads different research lines in pharmacogenetics of fluoropyrimidines, anti-TNF drugs (infliximab and adalimumab), opioids and multiple sclerosis drugs.

4. Conflict of interest

None

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.